We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+1.2%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.6B
AUM Growth
+$669M
(+1.8%)
Cap. Flow
+$1.61B
Cap. Flow
% of AUM
4.18%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
2,814
New
394
Increased
941
Reduced
1,071
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$550M |
| 2 |
Eli Lilly
LLY
|
+$493M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$418M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$381M |
| 5 |
Meta Platforms (Facebook)
META
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$486M |
| 2 |
Pfizer
PFE
|
+$433M |
| 3 |
Apple
AAPL
|
+$430M |
| 4 |
Tesla
TSLA
|
+$401M |
| 5 |
Roku
ROKU
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.02% |
| 2 | Healthcare | 23.8% |
| 3 | Communication Services | 9.19% |
| 4 | Financials | 8.73% |
| 5 | Consumer Discretionary | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Keros Therapeutics
KROS
$199M
| $744K | ﹤0.01% |
18,800
+11,300
| +151% | +$402K |
|
|
ZYNE
1752
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $743K | ﹤0.01% |
175,300
+46,700
| +36% | +$208K |
|
1753
Coty
COTY
$2.42B
| $742K | ﹤0.01% |
+94,447
| New | +$808K |
|
1754
Plexus
PLXS
$6.72B
| $742K | ﹤0.01% |
8,300
-2,700
| -25% | -$240K |
|
|
EIGR
1755
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $740K | ﹤0.01% |
3,691
-2,167
| -37% | -$515K |
|
1756
CorMedix
CRMD
$591M
| $739K | ﹤0.01% |
159,000
-44,300
| -22% | -$258K |
|
1757
Universal Logistics Holdings
ULH
$353M
| $735K | ﹤0.01% |
36,600
+19,100
| +109% | +$413K |
|
|
LRFC
1758
DELISTED
Logan Ridge Finance Corp
LRFC
| $734K | ﹤0.01% |
28,572
-3,900
| -12% | -$104K |
|
1759
S&T Bancorp
STBA
$1.84B
| $731K | ﹤0.01% |
+24,800
| New | +$731K |
|
1760
Capital City Bank Group
CCBG
$888M
| $730K | ﹤0.01% |
29,500
+3,100
| +12% | +$73.8K |
|
|
RPT
1761
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $730K | ﹤0.01% |
57,186
-10,800
| -16% | -$138K |
|
1762
Entravision Communication
EVC
$1.03B
| $725K | ﹤0.01% |
102,100
-99,200
| -49% | -$670K |
|
1763
Cytosorbents Corp
CTSO
$22.7M
| $723K | ﹤0.01% |
89,000
-52,300
| -37% | -$425K |
|
1764
HCI Group
HCI
$2.23B
| $720K | ﹤0.01% |
6,500
-7,800
| -55% | -$813K |
|
1765
Woodward
WWD
$21.3B
| $720K | ﹤0.01% |
6,361
-19,100
| -75% | -$2.27M |
|
|
BRT
1766
BRT Apartments
BRT
$281M
| $719K | ﹤0.01% |
37,300
+17,800
| +91% | +$330K |
|
1767
National Health Investors
NHI
$3.72B
| $718K | ﹤0.01% |
13,417
-60,806
| -82% | -$3.8M |
|
|
BMTC
1768
DELISTED
Bryn Mawr Bank Corp
BMTC
| $718K | ﹤0.01% |
15,619
+2,000
| +15% | +$80.8K |
|
1769
Donegal Group Class A
DGICA
$731M
| $717K | ﹤0.01% |
49,500
-10,600
| -18% | -$159K |
|
1770
Globalstar
GSAT
$10.7B
| $717K | ﹤0.01% |
+28,607
| New | +$702K |
|
1771
Eledon Pharmaceuticals
ELDN
$261M
| $716K | ﹤0.01% |
115,900
+37,600
| +48% | +$263K |
|
1772
Consolidated Water Co
CWCO
$467M
| $715K | ﹤0.01% |
62,700
-6,600
| -10% | -$79.5K |
|
1773
Business First Bancshares
BFST
$1.04B
| $713K | ﹤0.01% |
+30,500
| New | +$708K |
|
1774
Minerals Technologies
MTX
$2.36B
| $712K | ﹤0.01% |
10,200
+5,300
| +108% | +$405K |
|
|
AFIB
1775
DELISTED
Acutus Medical Inc
AFIB
| $710K | ﹤0.01% |
+80,300
| New | +$1.06M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, Two Sigma Advisers held 2,814 positions worth $38.6B, up 1.8% from $37.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $1.61B of net new capital in Q3 2021, opening 394 new positions and adding to 941 existing holdings. Its largest new stake was Danaher: 1,248,470 shares worth $337M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $486M trimmed.
- Two Sigma Advisers's largest Q3 2021 buy was Danaher: 1,248,470 shares worth $337M.
- Two Sigma Advisers added most to Microsoft in Q3 2021, an estimated $550M increase.
- Two Sigma Advisers's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $486M.
- Two Sigma Advisers fully exited Roku in Q3 2021, selling an estimated $374M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $38.6B portfolio in Q3 2021.
- Two Sigma Advisers opened 394 new positions and closed 396 in Q3 2021.
- Two Sigma Advisers's portfolio value rose 1.8% quarter-over-quarter to $38.6B.
Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.